(Q33362778)
Statements
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection (English)
Robert W Coombs
Gary Calandra
Karin Badel
Ann C Collier
Marshall J Glesby
Craig W Hendrix
Michael M Lederman
Richard B Pollard
Stephen Brown
Charles W Flexner
Gary J Bridger
Ronald T MacFarland
Geoffrey W Henson
AMD3100 HIV Study Group